The Foundation for Sarcoidosis Research (FSR) has launched the Coalition for Clinical Trial Equity, aimed at increasing the…
Articles by Patricia Inácio, PhD
The Phase 2 clinical trial RESOLVE-Lung, which is testing namilumab as a treatment for people with chronic pulmonary sarcoidosis,…
A first patient has been dosed in Scotland as part of Molecure’s Phase 2 clinical trial — taking place in…
Elevated blood levels of total blood cholesterol and low levels of high density lipoprotein cholesterol (HDL) — commonly called the…
A noninvasive heart imaging scan may help identify cardiac sarcoidosis patients at risk of worse clinical outcomes, according to…
In Finland, only 2% of sarcoidosis patients without symptoms of eye involvement indeed had ocular sarcoidosis, suggesting that…
About six months with Acthar Gel were associated with greater therapeutic benefits than a placebo in people with…
After the success of its virtual event last year, the Foundation for Sarcoidosis Research (FSR) is gearing up to once…
The Foundation for Sarcoidosis Research (FSR) has launched the FSR Global Sarcoidosis Clinic Alliance, a hub of clinics and hospitals…
A recent technique for collecting lung tissue for analysis, called transbronchial lung cryobiopsy, is better than more conventional methods for…